Lima, Peru Clinical Trials

A listing of Lima, Peru clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 100 clinical trials
Evaluating Newly Approved Drugs in Combination Regimens for Multidrug-Resistant TB With Fluoroquinolone Resistance (endTB-Q)

endTB-Q Clinical Trial is a Phase III, randomized, controlled, open-label, non-inferiority, multi-country trial evaluating the efficacy and safety of two new, all-oral, shortened regimens for multidrug-resistant tuberculosis (MDR-TB) with fluoroquinolone resistance.

bedaquiline
linezolid
delamanid
clofazimine
linezolid pill
Partners In Health Lesostho
 (6636.3 away) Contact site
  • 94 views
  • 17 Sep, 2021
  • +5 other locations
Study of Mavrilimumab (KPL-301) in Participants Hospitalized With Severe Corona Virus Disease 2019 (COVID-19) Pneumonia and Hyper-inflammation

Interventional, randomized, double-blind, placebo-controlled study encompassing 2 development phases (Phase 2 and Phase 3).

pneumonia
covid-19
mechanical ventilation
SARS
fever
Hospital Arzobispo Loayza
 (0.8 away) Contact site
  • 122 views
  • 17 Mar, 2021
  • +32 other locations
Efficacy and Safety of Gefapixant (MK-7264) in Women With Chronic Cough and Stress Urinary Incontinence (MK-7264-042)

The purpose of this study is to evaluate the efficacy and safety of gefapixant, in improving symptoms of cough-induced stress urinary incontinence (SUI) in adult female participants with refractory or unexplained chronic cough. The primary hypothesis is that gefapixant is superior to placebo in reducing the frequency of cough-induced SUI …

refractory chronic cough
gefapixant
unexplained chronic cough
chest radiograph
Hospital Nacional Arzobispo Loayza ( Site 0607)
 (0.8 away) Contact site
  • 88 views
  • 26 Sep, 2021
  • +89 other locations
Study of Efficacy and Safety of Ligelizumab in Chronic Spontaneous Urticaria Patients Who Completed a Previous Study With Ligelizumab

The purpose of this extension study is to establish efficacy and safety of ligelizumab. This will be assessed in adult and adolescent chronic spontaneous urticaria (CSU) patients who have completed a preceding ligelizumab study and have relapsed, following treatment in these preceding studies, despite standard of care H1-antihistamine (H1-AH) treatment. …

ligelizumab
urticaria
antihistamines
Novartis Investigative Site
 (4.9 away) Contact site
  • 1 views
  • 29 Aug, 2021
  • +229 other locations
Pivotal Study to Assess the Efficacy Safety and Tolerability of Dupilumab in Patients With Moderate to Severe COPD With Type 2 Inflammation

Primary Objective: To evaluate the efficacy of dupilumab administered every 2 weeks in patients with moderate or severe Chronic Obstructive Pulmonary Disease (COPD) as measured by Annualized rate of acute moderate or severe COPD exacerbation (AECOPD) Secondary Objectives: To evaluate the effect of dupilumab administered every 2 weeks on Pre-bronchodilator …

muscarinic antagonists
dyspnea
pulmonary function test
eosinophil count
severe chronic obstructive pulmonary disease
Investigational Site Number 6040003
 (36.4 away) Contact site
  • 156 views
  • 26 Sep, 2021
  • +223 other locations
Study Assessing the Efficacy and Safety of Alpelisib + Nab-paclitaxel in Subjects With Advanced TNBC Who Carry Either a PIK3CA Mutation or Have PTEN Loss

The purpose of this study is to determine whether treatment with alpelisib in combination with nab-paclitaxel is safe and effective in subjects with advanced triple negative breast cancer (aTNBC) who carry either a PIK3CA mutation (Study Part A) or have PTEN loss (Study Part B1) or PTEN loss without PIK3CA …

paclitaxel
cancer
metastasis
measurable disease
PTEN
Novartis Investigative Site
 (5.9 away) Contact site
  • 5 views
  • 20 Sep, 2021
  • +153 other locations
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)

The purpose of this study is to assess the efficacy and safety of pembrolizumab in combination with concurrent chemoradiation therapy followed by either pembrolizumab with olaparib placebo (Arm 1) or with olaparib (Arm 2) compared to concurrent chemoradiation therapy followed by durvalumab (Arm 3) in participants with unresectable, locally advanced …

paclitaxel
metastasis
etoposide
cancer chemotherapy
pembrolizumab
Hospital Nacional Cayetano Heredia ( Site 0602)
 (1.5 away) Contact site
  • 51 views
  • 26 Sep, 2021
  • +191 other locations
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus

The purpose of this study is to evaluate the ability of dapirolizumab pegol (DZP) as an add-on treatment to standard of care (SOC) medication to achieve clinically relevant long term improvement of moderate to severe disease activity.

rheumatism
sjogren's syndrome
lupus
immunosuppressive agents
antinuclear antibody
Sl0043 60020
 (4.5 away) Contact site
  • 10 views
  • 12 Sep, 2021
  • +159 other locations
Capivasertib+Abiraterone as Treatment for Patients With Metastatic Hormone-sensitive Prostate Cancer and PTEN Deficiency

This study will assess the efficacy and safety of capivasertib plus abiraterone (+prednisone/prednisolone) plus androgen deprivation therapy (ADT) versus placebo plus abiraterone (+prednisone/prednisolone) plus ADT in participants with mHSPC whose tumours are characterised by PTEN deficiency. The intention of the study is to demonstrate that in participants with mHSPC, the …

Research Site
 (1.0 away) Contact site
  • 111 views
  • 18 Sep, 2021
  • +290 other locations
Drug-Drug Interactions Between Rifapentine and Dolutegravir in HIV/LTBI Co-Infected Individuals

This study will evaluate the potential drug-drug interactions between dolutegravir (DTG) and steady state rifapentine (RPT) when RPT is given with isoniazid (INH) daily for 4 weeks (1HP) as part of treatment for latent TB infection (LTBI) in HIV-1 and LTBI co-infected individuals.

urine test
western blot
hysterectomy
total bilirubin
tuberculin test
Barranco CRS
 (7.9 away) Contact site
  • 0 views
  • 30 Aug, 2021
  • +10 other locations